Nanotechnology-based products for cancer immunotherapy

被引:0
作者
Forough Shams
Ali Golchin
Arezo Azari
Leila Mohammadi Amirabad
Fateme Zarein
Atiyeh Khosravi
Abdolreza Ardeshirylajimi
机构
[1] Shahid Beheshti University of Medical Sciences,School of Advanced Technologies in Medicine
[2] Urmia University of Medical Sciences,Department of Clinical Biochemistry and Applied Cell Sciences, School of Medicine
[3] Cultured Decadence,Department of Nanobiotechnology, Faculty of Biological Sciences
[4] Inc.,Urogenital Stem Cell Research Center
[5] Tarbiat Modares University,undefined
[6] Shahid Beheshti University of Medical Sciences,undefined
[7] SinaCell Research and Product Center,undefined
来源
Molecular Biology Reports | 2022年 / 49卷
关键词
Cancer; Immunotherapy; Regenerative medicine; Nanotechnology; Neoplasms;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1389 / 1412
页数:23
相关论文
共 360 条
[1]  
Liu Y(2012)Cancer and innate immune system interactions: translational potentials for cancer immunotherapy J Immunother 35 299-308
[2]  
Zeng G(2020)Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer Sci Adv 6 eaax5032-204
[3]  
Huang K-W(2015)Immunoengineering: how nanotechnology can enhance cancer immunotherapy Cell 161 201-e178
[4]  
Hsu F-F(2018)New opportunities for nanoparticles in cancer immunotherapy Biomater Res 22 24-39
[5]  
Qiu JT(2020)CAR T cells: continuation in a revolution of immunotherapy Lancet Oncol 21 e168-524
[6]  
Goldberg MS(2020)Tumour-intrinsic resistance to immune checkpoint blockade Nat Rev Immunol 20 25-658
[7]  
Park W(2020)Molecular aspects and future perspectives of cytokine-based anti-cancer immunotherapy Front Cell Dev Biol 8 402-133
[8]  
Heo YJ(2014)Therapeutic vaccines for cancer: an overview of clinical trials Nat Rev Clin Oncol 11 509-1259
[9]  
Han DK(2011)Dual roles of immune cells and their factors in cancer development and progression Int J Biol Sci 7 651-12
[10]  
Singh AK(2020)Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy Cancer Lett 470 126-11146